GenomeWeb/Mizuho Survey Finds Researchers Optimistic for Sequencing Funding, Market Growth
June 14, 2011
GenomeWeb/Mizuho Survey Finds Researchers Optimistic for Sequencing Funding, Market Growth
The survey found that respondents expect sequencing to overtake microarrays in most applications within five years, that they believe sequencing will penetrate the consumer market within approximately six years, and that the average price point at which most respondents would get their genome sequenced is $700.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Researchers Rank MiSeq over PGM for Usability; Expect Their Sequencing Output to Grow by Half in 2013
January 22, 2013 / In Sequence - Researchers Foresee 40 Percent Increase in Sequenced Human Genomes in 2013
July 31, 2012 / In Sequence - Survey Finds MiSeq, Ion PGM Tied for Most Likely Sequencing Purchase over Next 12 Months
April 24, 2012 / In Sequence - Survey: Sequencing Output to Grow by 32 Percent in 2012; High Interest in Single-Molecule Systems
January 17, 2012 / In Sequence - Survey Finds Researchers Most Likely to Purchase Ion Torrent PGM, MiSeq, HiSeq over Next Year
October 25, 2011 / In Sequence